MALDI-TOF Biotyper Sirius
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), specifically the FDA Office of Acquisition & Grant Services, is seeking a Bruker MALDI-TOF Biotyper Sirius one GP system for its Moffett Laboratory in Bedford Park, IL. This Combined Synopsis/Solicitation (RFQ) aims to replace an obsolete instrument critical for detecting and characterizing Clostridium botulinum neurotoxins using the Endopep-MS assay, supporting the Laboratory Response Network (LRN) and public health protection. Quotes are due March 10, 2026, at 4:00 PM ET.
Purpose & Objective
The primary objective is to acquire, install, and validate one FDA-approved benchtop MALDI-TOF mass spectrometer system. This system will ensure uninterrupted capability for high-throughput detection, differentiation, and characterization of botulinum neurotoxins, eliminating the need for traditional animal testing and supporting rapid response in large-scale events.
Scope of Work
The contractor shall provide:
- One (1) Bruker MALDI-TOF Biotyper Sirius one GP system (new, current production model)
- Required software (including MBT Compass HT Industry Software Package) and validated reference libraries
- A dedicated computer workstation meeting specified requirements (e.g., quad-core CPU, 12 GB RAM, 2 TB HDD)
- Associated peripherals and accessories (e.g., UPS, color printer)
- On-site installation, operational qualification, and system calibration
- Two (2) days of on-site application training
- Minimum one (1) year full warranty (parts, labor, travel) with 48-hour response time
- Freight, shipping, and delivery to FDA Moffett Laboratory, 6502 S. Archer Rd., Bedford Park, IL 60501.
Key Requirements
- Instrument: FDA-approved, benchtop MALDI-TOF mass spectrometer supporting Endopep-MS assay and microorganism identification.
- Software: MS data acquisition/processing, automated data analysis, microorganism identification/classification, reference library access, audit trail, and compliance with FDA IT/security policies.
- Delivery: Within 60 days of contract award.
- Compliance: Adherence to FDA laboratory safety, electrical/environmental standards, and federal, state, and local regulations.
Contract Details
- Contract Type: Firm-fixed-price quote required.
- Period of Performance: One (1) year base period.
- Set-Aside: This acquisition is not set-aside for small business concerns.
Submission & Evaluation
- Quotes Due: March 10, 2026, 4:00 PM ET.
- Question Deadline: April 7, 2026, 12:00 PM ET.
- Submission Format: Offers must be submitted in two separate volumes: Volume I (Technical, 10-page limit, no pricing) and Volume II (Price, including completed pricing schedule).
- Evaluation Factors: Offers will be evaluated based on Technical and Price, which are approximately equal in importance. The Government intends to make an award without discussions.
- Required Information: Quotes must reference the RFQ number and include company name, point of contact, GSA schedule contract number (if applicable), and UEI.
Contact Information
- Primary Contact: Erika Crawford (erika.crawford@fda.hhs.gov, 301-796-0298).